PROPOSED AGENDA: DAY ONE

Slides:

Advertisements

Similar presentations

IVF In Palestine Do We Need REGULATIONS? Dr. Salem Abu Khaizaran.

Advertisements

Preimplantation Genetic Diagnosis

Reproductive Technology, Genetic Testing, and Gene Therapy

ASSISTED REPRODUCTIVE TECHNOLOGIES Andrea Miller, Aquilla Reed, Ellen Salomon.

Postnatal screening – Pre-implantation genetic diagnosis.

Reproductive Technology Chapter 21. Assisted Reproduction When a couple is sub-fertile or infertile they may need Assisted Reproduction to become pregnant:

Department of ART for Infertility Treatmet Research Centre of Ob/Gyn &Perinatology Named After V.I. Kulakov Ministry of Health And Social Development of.

In Vitro Fertilization and Preimplantation Genetic Diagnosis

In Vitro Fertilisation (IVF) IVF enables fertilisation, outside the body, in a culture dish.

Fertility Diagnosis and Therapy 2008 Gad Lavy, M.D. New England Fertility Institute Lifeline Cryogenics.

NOTES - In Vitro Fertilization & Genetic Screening.

Preimplantation Genetic Diagnosis (PGD)

The genetic counsellor When there is a possibility that a couple may have a child with a genetic disease, they may be referred to a genetic counsellor.

New England Fertility Institute Lifeline Cryogenics Gad Lavy, M.D., F.A.C.O.G. Life begins here…

Genetic Testing. What is Genetic Testing? Analysis of human DNA, chromosomes and/or proteins Analysis of human DNA, chromosomes and/or proteins Used to:

 There are about 900 tests available for discovering genetic abnormalities.  Reasons for such testing include: › Finding possible genetic diseases in.

Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.

Chapter 6 – Pedigree Analysis and Applications

CLONING 101. cloning is the creation of an organism that is the EXACT genetic copy of another –Identical twins are natural clones Cloning can be done.

Assisted Reproductive Techniques (ART) Biological Science

Chapter 2: Biological Beginnings ©2011 The McGraw-Hill Companies, Inc. All rights reserved. Life-Span Development Thirteenth Edition.

Assisted Reproductive Technologies Chapter 6.3. Assisted Reproductive Technologies Many couples can be infertile due to complications related to the reproductive.

International Workshop Magnetic Phenomena in Micro- and Nano-Structures 27–29 May Donetsk, Ukraine.

In Vitro Fertilisation (IVF) IVF enables fertilisation, outside the body, in a culture dish.

Anish A. Shah, MD, MHS, FACOG B OARD C ERTIFIED R EPRODUCTIVE E NDOCRINOLOGIST Preimplantation Genetic Testing Gateway to the Future of Fertility Dennis.

Avoiding Transmission of Genetic Disease Avoiding Transmission of Genetic Disease Professor Peter Braude Division of Women’s Health Kings College, London.

Reproductive biology 1/ Reproductive organs and hormonal control 2/ The biology of fertility control 3/ Ante-natal and post-natal screening.

Biology of Fertility Control

BC Science 9: p Infertility  Infertility is the inability of a couple to have a baby.  Approximately three in twenty couples are infertile.

Building Strong Library Associations | Regional Convenings DAY 4 Session 2 Action plan presentations.

Genetics Lec.3. Chromosomal abnormalities Incidence is 1: 200 newborn, but it is much higher during pregnancy (50% in the first trimester abortions).

 What if you could screen embryos for diseases before they became babies?  What if you could choose the traits your baby would have?  Would you use.

Fertility Facts Definition:unprotected sex for one year, not pregnant

 Generally in the ivf procedure, the sperm and the egg are kept for fertilization inside the body of a woman. When the fertilized egg is attached to the.

Genetic Disorders and Genetic Testing

Preimplantation Genetic Diagnosis Market Analysis And Segment Forecasts To 2024 Phone No.: +1 (214) id:

In The Name Of God. In The Name Of God Prenatal Diagnosis of Congenital Disorders Dr. Gita Hatamizadeh OBGYN- Infertility Fellowship Assisted professor.

A – The reproductive system

Research on Pre-implantation Embryos: Ethical Imperatives

Human Genetic Engineering

13.2 – Human Genetic Disorders

Intro Until recently, couples had to choose between taking the risk or considering other options Over the past three decades, prenatal diagnosis-the.

Poster Title OBJECTIVE DISCUSSION CONCLUSIONS DESIGN REFERENCES

IVF (In Vitro Fertilization)

OLADAPO ASHIRU, MB,BS, PHD,HCLD/CC.

Pre conceptual care.

Preimplantation Genetic Diagnosis (PGD)

V. How Does Evolution Work?

Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.

PROVISIONAL PROGRAM, PGDIS 2018: DAY ONE

Chapter 2: Biological Beginnings

What makes a mutant?.

Genetic Counselling.

c The biology of controlling fertility

Genetic Testing.

6.3 Assisted Reproductive Technologies

NOTES 25 - In Vitro Fertilization & Genetic Screening

PGD for cystic fibrosis patients and couples at risk of an additional genetic disorder combined with 24-chromosome aneuploidy testing Svetlana Rechitsky,

First systematic experience of preimplantation genetic diagnosis for de-novo mutations Svetlana Rechitsky, Ekaterina Pomerantseva, Tatiana Pakhalchuk,

Understanding IVF Processes in Surrogacy

H2020 – SCREEN 1st International Workshop

MEIOSIS 11-4 Making gametes…

Genetic Disorders and Genetic Testing

In Vitro Fertilization and Prenatal Diagnosis DENIZ ESER MERVE GÜLMEZ SELEN İREM GORALI

Concepts and Applications Seventh Edition

APPLICATION OF VITRIFICATION IN GENETIC ART

V. How Does Evolution Work?

RSMC Services. We help individuals and couples overcome obstacles to achieve their dream of a family, regardless of nationality, sexual orientation or.

Reproductive Technology

Presentation transcript:

PROPOSED AGENDA: DAY ONE Block Time Type Title 8:45-9:00 Welcome 9:00-9:30 Plenary Lecture The Evolution of PGT-A 9:30-11:00 9:30-10:00 Session 1: PGT-A in ART PGT-A “in house”, is it safe and cost effective? 10:00-11:00 PGT-A as QC for IVF methods 11:00-11:30 Differences in amplification methods for PGT-A Coffee Break 11:30-13:30 11:30-12:00 Session 2: Progress in PGT for Inherited Conditions Strategies for PGT-M for de novo mutations 12:00-12:30 PGT-M for Borderline Indications 12:30-13:00 PGT for structural rearrangements (PGT-SR) 13:00-13:30 PGT for multiple genetic diseases 13:30-14:30 Break Lunch and POSTER SESSION 14:30-16:00 Session 3: Abstracts 15 min per each abstract x 6 16:00-16:30 16:30-17:00 Session 4 Endometrial Receptivity, what time is ideal time to transfer? 17:00-17:30 Prospect of PGT for epigenetic inheritance 9/20/2018

PROPOSED AGENDA: DAY TWO Block Time Type Title 8:00-8:15 Summary highlights from day one 8:15-8:45 Plenary lecture Origins of meiotic and post mitotic aneuploidy? 8:45-10:45 8:45-9:15 Session 5: Mosaicism and Segmentals Impact of Mosaicism and Segmentals on outcomes 9:15-9:45 Improvement and standardization of biopsy procedures 9:45-10:15 How to counsel around Mosaicism and Segmentals 10:15-10:45 DISCUSSION/ DEBATE 10:45-11:15 Coffee Break 11:15-13:00 Session 6: Abstracts 15 min per each abstract x 7 13:00-14:00 BREAK Lunch and POSTER SESSION 14:00-15:30 Session 7: Regional Block 15 min per each abstract x 6 15:30-16:00 16:00-17:30 16:00-16:30 Session 8: Prospective Carrier screening for identification of at risk PGT couples Genetic Panels for ovarian, breast and endometrial cancers 16:30-17:00 Genetic Panels for Infertility 17:00-17:30 Prospective gene testing of sperm and egg donors 9/20/2018

PROPOSED AGENDA: DAY THREE Block Time Type Title 8:00-8:15 Summary highlights from day two 8:15-8:45 Plenary lecture 3 person babies 8:45-10:15 8:45-9:15 Session 9: Reproductive Outcome of PGT-A RCT PGD v1–based on FISH 9:15-9:45 RCT PGD v2– Based on Next Generation Technologies 9:45-10:15 Debate: on STAR trial 10:15-10:45 Luteal support protocols and embryo chromosome abnormalities 10:45-11:15 Coffee Break 11:15-12:00 Session 10: Abstracts 15 min per each abstract x 3 12:00-13:00 Session 11: Regional Block 15 min per each abstract x 4 BREAK Lunch and POSTER SESSION 14:00-15:30 14:00-14:30 Session 12: Emerging Technologies. CRISPR-based gene editing 14:30-15:00 Non invasive PGD-A using blastocell fluid 15:00-15:30 Non invasive PGD-A using spent medium Late Breaking News TBD based on submission 15:30-16:00 Closing remarks 9/20/2018